share_log
Reuters ·  Dec 20 22:38
Eli Lilly Shares up 5.8% After Novo Nordisk's Cagrisema Achieves Lower-Than-Expected Weight Loss in Trial
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment